GO:1901363 | heterocyclic compound binding | 18.56% (31/167) | 2.04 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 18.56% (31/167) | 2.04 | 0.0 | 0.0 |
GO:0035639 | purine ribonucleoside triphosphate binding | 10.18% (17/167) | 2.49 | 0.0 | 1e-06 |
GO:0032553 | ribonucleotide binding | 10.18% (17/167) | 2.41 | 0.0 | 1e-06 |
GO:0017076 | purine nucleotide binding | 10.18% (17/167) | 2.42 | 0.0 | 1e-06 |
GO:0097367 | carbohydrate derivative binding | 10.18% (17/167) | 2.38 | 0.0 | 1e-06 |
GO:0005488 | binding | 27.54% (46/167) | 1.22 | 0.0 | 1e-06 |
GO:0051641 | cellular localization | 4.79% (8/167) | 3.97 | 0.0 | 2e-06 |
GO:0032555 | purine ribonucleotide binding | 10.18% (17/167) | 2.42 | 0.0 | 2e-06 |
GO:1901265 | nucleoside phosphate binding | 10.18% (17/167) | 2.23 | 0.0 | 4e-06 |
GO:0000166 | nucleotide binding | 10.18% (17/167) | 2.23 | 0.0 | 4e-06 |
GO:0043168 | anion binding | 10.18% (17/167) | 2.21 | 0.0 | 5e-06 |
GO:0006886 | intracellular protein transport | 4.19% (7/167) | 4.03 | 0.0 | 5e-06 |
GO:0036094 | small molecule binding | 10.18% (17/167) | 2.19 | 0.0 | 6e-06 |
GO:0005524 | ATP binding | 8.38% (14/167) | 2.42 | 0.0 | 9e-06 |
GO:0046907 | intracellular transport | 4.19% (7/167) | 3.85 | 1e-06 | 1.2e-05 |
GO:0015833 | peptide transport | 4.19% (7/167) | 3.74 | 1e-06 | 1.3e-05 |
GO:0015031 | protein transport | 4.19% (7/167) | 3.74 | 1e-06 | 1.3e-05 |
GO:0045184 | establishment of protein localization | 4.19% (7/167) | 3.74 | 1e-06 | 1.3e-05 |
GO:0042886 | amide transport | 4.19% (7/167) | 3.74 | 1e-06 | 1.3e-05 |
GO:0008104 | protein localization | 4.19% (7/167) | 3.72 | 1e-06 | 1.3e-05 |
GO:0033036 | macromolecule localization | 4.19% (7/167) | 3.72 | 1e-06 | 1.3e-05 |
GO:0008144 | drug binding | 8.38% (14/167) | 2.35 | 1e-06 | 1.3e-05 |
GO:0051649 | establishment of localization in cell | 4.19% (7/167) | 3.8 | 1e-06 | 1.4e-05 |
GO:0032559 | adenyl ribonucleotide binding | 8.38% (14/167) | 2.34 | 1e-06 | 1.4e-05 |
GO:0030554 | adenyl nucleotide binding | 8.38% (14/167) | 2.33 | 1e-06 | 1.4e-05 |
GO:0071705 | nitrogen compound transport | 4.19% (7/167) | 3.56 | 2e-06 | 2.7e-05 |
GO:0071702 | organic substance transport | 4.19% (7/167) | 3.49 | 3e-06 | 3.6e-05 |
GO:0003676 | nucleic acid binding | 8.38% (14/167) | 1.89 | 2.8e-05 | 0.000323 |
GO:0005634 | nucleus | 2.99% (5/167) | 3.65 | 4.8e-05 | 0.000533 |
GO:0043229 | intracellular organelle | 3.59% (6/167) | 3.19 | 5.3e-05 | 0.000571 |
GO:0044424 | intracellular part | 5.99% (10/167) | 2.23 | 5.9e-05 | 0.000616 |
GO:0006725 | cellular aromatic compound metabolic process | 5.99% (10/167) | 2.22 | 6.4e-05 | 0.000632 |
GO:0043226 | organelle | 3.59% (6/167) | 3.14 | 6.4e-05 | 0.000647 |
GO:0046483 | heterocycle metabolic process | 5.99% (10/167) | 2.17 | 8.5e-05 | 0.000816 |
GO:1901360 | organic cyclic compound metabolic process | 5.99% (10/167) | 2.15 | 9.3e-05 | 0.000862 |
GO:0090304 | nucleic acid metabolic process | 4.79% (8/167) | 2.46 | 0.000111 | 0.001006 |
GO:0009987 | cellular process | 14.37% (24/167) | 1.18 | 0.000139 | 0.001229 |
GO:0034641 | cellular nitrogen compound metabolic process | 5.99% (10/167) | 2.07 | 0.000149 | 0.001281 |
GO:0003674 | molecular_function | 36.53% (61/167) | 0.62 | 0.000153 | 0.001282 |
GO:0006139 | nucleobase-containing compound metabolic process | 5.39% (9/167) | 2.19 | 0.000176 | 0.00144 |
GO:0043231 | intracellular membrane-bounded organelle | 2.99% (5/167) | 3.23 | 0.000194 | 0.001447 |
GO:0043227 | membrane-bounded organelle | 2.99% (5/167) | 3.23 | 0.000194 | 0.001447 |
GO:0016070 | RNA metabolic process | 4.19% (7/167) | 2.57 | 0.000186 | 0.001449 |
GO:0140098 | catalytic activity, acting on RNA | 2.99% (5/167) | 3.25 | 0.000182 | 0.00145 |
GO:0043167 | ion binding | 10.18% (17/167) | 1.42 | 0.000223 | 0.001622 |
GO:0044464 | cell part | 6.59% (11/167) | 1.87 | 0.00023 | 0.001638 |
GO:0003690 | double-stranded DNA binding | 1.8% (3/167) | 4.25 | 0.000498 | 0.003403 |
GO:0030983 | mismatched DNA binding | 1.8% (3/167) | 4.25 | 0.000498 | 0.003403 |
GO:0003677 | DNA binding | 4.19% (7/167) | 2.18 | 0.000948 | 0.006352 |
GO:0034660 | ncRNA metabolic process | 2.4% (4/167) | 3.11 | 0.00121 | 0.007948 |
GO:0006807 | nitrogen compound metabolic process | 11.98% (20/167) | 1.08 | 0.001234 | 0.007953 |
GO:0016877 | ligase activity, forming carbon-sulfur bonds | 1.2% (2/167) | 4.74 | 0.002415 | 0.01498 |
GO:0008641 | ubiquitin-like modifier activating enzyme activity | 1.2% (2/167) | 4.74 | 0.002415 | 0.01498 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 1.8% (3/167) | 3.44 | 0.002664 | 0.016224 |
GO:0097747 | RNA polymerase activity | 1.8% (3/167) | 3.32 | 0.003332 | 0.019582 |
GO:0034062 | 5'-3' RNA polymerase activity | 1.8% (3/167) | 3.32 | 0.003332 | 0.019582 |
GO:0016072 | rRNA metabolic process | 1.2% (2/167) | 4.48 | 0.003507 | 0.019912 |
GO:0006364 | rRNA processing | 1.2% (2/167) | 4.48 | 0.003507 | 0.019912 |
GO:0032549 | ribonucleoside binding | 1.8% (3/167) | 2.89 | 0.00775 | 0.022774 |
GO:0005525 | GTP binding | 1.8% (3/167) | 2.89 | 0.00775 | 0.022774 |
GO:0032550 | purine ribonucleoside binding | 1.8% (3/167) | 2.89 | 0.00775 | 0.022774 |
GO:0001883 | purine nucleoside binding | 1.8% (3/167) | 2.89 | 0.00775 | 0.022774 |
GO:0001882 | nucleoside binding | 1.8% (3/167) | 2.89 | 0.00775 | 0.022774 |
GO:0019001 | guanyl nucleotide binding | 1.8% (3/167) | 2.89 | 0.00775 | 0.022774 |
GO:0032561 | guanyl ribonucleotide binding | 1.8% (3/167) | 2.89 | 0.00775 | 0.022774 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:1905818 | regulation of chromosome separation | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0009081 | branched-chain amino acid metabolic process | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0051784 | negative regulation of nuclear division | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0051983 | regulation of chromosome segregation | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0051985 | negative regulation of chromosome segregation | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0071173 | spindle assembly checkpoint | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:1901987 | regulation of cell cycle phase transition | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0031577 | spindle checkpoint | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:1901988 | negative regulation of cell cycle phase transition | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0009082 | branched-chain amino acid biosynthetic process | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0045839 | negative regulation of mitotic nuclear division | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0033047 | regulation of mitotic sister chromatid segregation | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0010965 | regulation of mitotic sister chromatid separation | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0051783 | regulation of nuclear division | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0010948 | negative regulation of cell cycle process | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0033046 | negative regulation of sister chromatid segregation | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0033045 | regulation of sister chromatid segregation | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0033044 | regulation of chromosome organization | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:1905819 | negative regulation of chromosome separation | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:2001251 | negative regulation of chromosome organization | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0046654 | tetrahydrofolate biosynthetic process | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0005663 | DNA replication factor C complex | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0007093 | mitotic cell cycle checkpoint | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0031414 | N-terminal protein acetyltransferase complex | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0007094 | mitotic spindle assembly checkpoint | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0031417 | NatC complex | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0007088 | regulation of mitotic nuclear division | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0009396 | folic acid-containing compound biosynthetic process | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0042559 | pteridine-containing compound biosynthetic process | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0071174 | mitotic spindle checkpoint | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0046653 | tetrahydrofolate metabolic process | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0006760 | folic acid-containing compound metabolic process | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0045930 | negative regulation of mitotic cell cycle | 0.6% (1/167) | 7.06 | 0.007494 | 0.023462 |
GO:0016779 | nucleotidyltransferase activity | 1.8% (3/167) | 2.84 | 0.008567 | 0.024957 |
GO:0044238 | primary metabolic process | 11.38% (19/167) | 0.85 | 0.009222 | 0.026404 |
GO:0044281 | small molecule metabolic process | 2.99% (5/167) | 1.97 | 0.009217 | 0.026619 |
GO:0006520 | cellular amino acid metabolic process | 1.8% (3/167) | 2.79 | 0.009434 | 0.026782 |
GO:0044237 | cellular metabolic process | 10.18% (17/167) | 1.01 | 0.004851 | 0.027088 |
GO:0043170 | macromolecule metabolic process | 10.18% (17/167) | 1.01 | 0.004937 | 0.027111 |
GO:0034470 | ncRNA processing | 1.2% (2/167) | 3.74 | 0.009707 | 0.027326 |
GO:0019752 | carboxylic acid metabolic process | 2.4% (4/167) | 2.27 | 0.009795 | 0.027345 |
GO:0043436 | oxoacid metabolic process | 2.4% (4/167) | 2.25 | 0.0101 | 0.027963 |
GO:0019941 | modification-dependent protein catabolic process | 1.2% (2/167) | 3.67 | 0.010676 | 0.028385 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.2% (2/167) | 3.67 | 0.010676 | 0.028385 |
GO:0043632 | modification-dependent macromolecule catabolic process | 1.2% (2/167) | 3.67 | 0.010676 | 0.028385 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 1.2% (2/167) | 3.67 | 0.010676 | 0.028385 |
GO:0006082 | organic acid metabolic process | 2.4% (4/167) | 2.24 | 0.010411 | 0.028587 |
GO:0004386 | helicase activity | 1.2% (2/167) | 4.15 | 0.005498 | 0.029233 |
GO:0008150 | biological_process | 22.16% (37/167) | 0.6 | 0.005485 | 0.029636 |
GO:0034622 | cellular protein-containing complex assembly | 1.2% (2/167) | 3.6 | 0.011687 | 0.030827 |
GO:0044265 | cellular macromolecule catabolic process | 1.2% (2/167) | 3.54 | 0.012737 | 0.033336 |
GO:0071704 | organic substance metabolic process | 11.98% (20/167) | 0.87 | 0.006822 | 0.035709 |
GO:0006396 | RNA processing | 1.8% (3/167) | 2.94 | 0.006981 | 0.035977 |
GO:0006904 | vesicle docking involved in exocytosis | 0.6% (1/167) | 6.06 | 0.014932 | 0.035987 |
GO:0042558 | pteridine-containing compound metabolic process | 0.6% (1/167) | 6.06 | 0.014932 | 0.035987 |
GO:0006189 | 'de novo' IMP biosynthetic process | 0.6% (1/167) | 6.06 | 0.014932 | 0.035987 |
GO:0140056 | organelle localization by membrane tethering | 0.6% (1/167) | 6.06 | 0.014932 | 0.035987 |
GO:0140029 | exocytic process | 0.6% (1/167) | 6.06 | 0.014932 | 0.035987 |
GO:0000278 | mitotic cell cycle | 0.6% (1/167) | 6.06 | 0.014932 | 0.035987 |
GO:0006376 | mRNA splice site selection | 0.6% (1/167) | 6.06 | 0.014932 | 0.035987 |
GO:0051640 | organelle localization | 0.6% (1/167) | 6.06 | 0.014932 | 0.035987 |
GO:0048278 | vesicle docking | 0.6% (1/167) | 6.06 | 0.014932 | 0.035987 |
GO:0022406 | membrane docking | 0.6% (1/167) | 6.06 | 0.014932 | 0.035987 |
GO:0016043 | cellular component organization | 1.8% (3/167) | 2.58 | 0.013949 | 0.036223 |
GO:0071840 | cellular component organization or biogenesis | 1.8% (3/167) | 2.52 | 0.015682 | 0.037525 |
GO:0008194 | UDP-glycosyltransferase activity | 1.2% (2/167) | 3.36 | 0.016124 | 0.038309 |
GO:0005575 | cellular_component | 6.59% (11/167) | 1.07 | 0.016642 | 0.03926 |
GO:0009057 | macromolecule catabolic process | 1.2% (2/167) | 3.31 | 0.017329 | 0.040314 |
GO:0065003 | protein-containing complex assembly | 1.2% (2/167) | 3.31 | 0.017329 | 0.040314 |
GO:0051179 | localization | 5.39% (9/167) | 1.19 | 0.017933 | 0.041431 |
GO:0016874 | ligase activity | 1.2% (2/167) | 3.2 | 0.01985 | 0.045547 |
GO:0051129 | negative regulation of cellular component organization | 0.6% (1/167) | 5.48 | 0.022314 | 0.047312 |
GO:0033043 | regulation of organelle organization | 0.6% (1/167) | 5.48 | 0.022314 | 0.047312 |
GO:0006188 | IMP biosynthetic process | 0.6% (1/167) | 5.48 | 0.022314 | 0.047312 |
GO:0046040 | IMP metabolic process | 0.6% (1/167) | 5.48 | 0.022314 | 0.047312 |
GO:0010639 | negative regulation of organelle organization | 0.6% (1/167) | 5.48 | 0.022314 | 0.047312 |
GO:0007346 | regulation of mitotic cell cycle | 0.6% (1/167) | 5.48 | 0.022314 | 0.047312 |
GO:1903047 | mitotic cell cycle process | 0.6% (1/167) | 5.48 | 0.022314 | 0.047312 |
GO:0002161 | aminoacyl-tRNA editing activity | 0.6% (1/167) | 5.48 | 0.022314 | 0.047312 |
GO:0010564 | regulation of cell cycle process | 0.6% (1/167) | 5.48 | 0.022314 | 0.047312 |
GO:0031248 | protein acetyltransferase complex | 0.6% (1/167) | 5.48 | 0.022314 | 0.047312 |
GO:1902493 | acetyltransferase complex | 0.6% (1/167) | 5.48 | 0.022314 | 0.047312 |
GO:0043933 | protein-containing complex subunit organization | 1.2% (2/167) | 3.15 | 0.021165 | 0.048233 |
GO:0005515 | protein binding | 8.98% (15/167) | 0.82 | 0.023578 | 0.049678 |
GO:0032991 | protein-containing complex | 2.4% (4/167) | 1.88 | 0.023801 | 0.049834 |